S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
NASDAQ:EKSO

Ekso Bionics (EKSO) Price Target & Analyst Ratings

$0.73
+0.02 (+2.81%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.67
$0.74
50-Day Range
$0.67
$1.27
52-Week Range
$0.62
$1.88
Volume
13,532 shs
Average Volume
57,277 shs
Market Capitalization
$10.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Ekso Bionics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$9.00
1,127.83% Upside
High Prediction$9.00
Average Prediction$9.00
Low Prediction$9.00
TypeCurrent
10/1/22 to 10/1/23
1 Month Ago
9/1/22 to 9/1/23
3 Months Ago
7/3/22 to 7/3/23
1 Year Ago
10/1/21 to 10/1/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.00$9.00$9.00$9.00
Predicted Upside1,127.83% Upside484.42% Upside484.42% Upside420.23% Upside
Get Ekso Bionics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.


EKSO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EKSO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ekso Bionics Stock vs. The Competition

TypeEkso BionicsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside1,127.83% Upside869.81% Upside698.21% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/28/2023500.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingReiterates
3/30/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$9.00+484.41%
(Data available from 10/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












EKSO Price Target - Frequently Asked Questions

What is Ekso Bionics's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Ekso Bionics stock is Buy based on the current 1 buy rating for EKSO. The average twelve-month price prediction for Ekso Bionics is $9.00 with a high price target of $9.00 and a low price target of $9.00. Learn more on EKSO's analyst rating history.

Do Wall Street analysts like Ekso Bionics more than its competitors?

Analysts like Ekso Bionics more than other Medical companies. The consensus rating for Ekso Bionics is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how EKSO compares to other companies.

Does Ekso Bionics's stock price have much upside?

According to analysts, Ekso Bionics's stock has a predicted upside of 484.42% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:EKSO) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -